2003 SEP 4 - (NewsRx.com & NewsRx.net) -- HemoSense, Inc., a point-of-care blood coagulation monitoring system company, announced the closing of its latest round of funding.
Participating in this round were leading medical investment firms MPM Capital, Vanguard Venture Partners, MGVF III, Ltd., GC Technology Fund, LP, and Dade Bering.
Financial terms were not disclosed.
"The completion of this funding round is a testament to the strength of the HemoSense technology and markets we serve," said Jim Merselis, president and CEO of HemoSense. "The medical marketplace …
No comments:
Post a Comment